Thrivent Financial for Lutherans Sells 812 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Thrivent Financial for Lutherans lessened its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 1.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 79,769 shares of the company’s stock after selling 812 shares during the period. Thrivent Financial for Lutherans’ holdings in Privia Health Group were worth $1,559,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. FMR LLC raised its holdings in Privia Health Group by 1.5% in the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after acquiring an additional 271,645 shares during the last quarter. Riverbridge Partners LLC raised its stake in shares of Privia Health Group by 19.7% in the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after purchasing an additional 958,418 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Privia Health Group by 1.0% during the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock valued at $43,986,000 after purchasing an additional 23,178 shares in the last quarter. Franklin Resources Inc. boosted its position in shares of Privia Health Group by 2.2% during the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after buying an additional 28,480 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Privia Health Group by 6.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,133,873 shares of the company’s stock worth $22,167,000 after buying an additional 69,649 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on PRVA. Macquarie started coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 target price on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $30.00 price objective on shares of Privia Health Group in a report on Friday, March 21st. JMP Securities set a $29.00 price objective on Privia Health Group in a research report on Friday, February 28th. Piper Sandler raised their target price on Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, February 28th. Finally, Stephens reaffirmed an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $26.67.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $22.59 on Monday. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $26.04. The company has a market capitalization of $2.72 billion, a P/E ratio of 225.92, a P/E/G ratio of 3.47 and a beta of 0.85. The company has a fifty day moving average of $23.80 and a 200 day moving average of $21.20.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.